Detalles de la búsqueda
1.
Difficulties in diagnosing phenoconversion to dementia in psychiatric-onset prodromal dementia with Lewy bodies.
Psychogeriatrics
; 24(3): 725-726, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38382551
2.
Association of premorbid personality with behavioral and psychological symptoms in dementia with Lewy bodies: Comparison with Alzheimer's disease patients.
Psychiatry Clin Neurosci
; 71(6): 409-416, 2017 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-28177178
3.
Real-world effectiveness of antipsychotic treatments in 1011 acutely hospitalized patients with schizophrenia: A one-year follow-up study.
Asian J Psychiatr
; 67: 102917, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34875558
4.
Development of a Novel Nutrition-Related Multivariate Biomarker for Mild Cognitive Impairment Based on the Plasma Free Amino Acid Profile.
Nutrients
; 14(3)2022 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35276996
5.
Decreased circulating branched-chain amino acids are associated with development of Alzheimer's disease in elderly individuals with mild cognitive impairment.
Front Nutr
; 9: 1040476, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36590218
6.
Real-world effectiveness of antipsychotic monotherapy and polytherapy in 1543 patients with acute-phase schizophrenia.
Asian J Psychiatr
; 40: 82-87, 2019 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-30772732
7.
A prospective naturalistic multicenter study on choice of parenteral medication in psychiatric emergency settings in Japan.
Neuropsychopharmacol Rep
; 38(3): 117-123, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-30175524
8.
Inter- and intra-observer reproducibility of quantitative analysis for FP-CIT SPECT in patients with DLB.
Ann Nucl Med
; 31(10): 758-763, 2017 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-28913731
9.
Antipsychotic switching versus augmentation among early non-responders to risperidone or olanzapine in acute-phase schizophrenia.
Schizophr Res
; 158(1-3): 213-22, 2014 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-25086659
10.
The possibility that requiring high-dose olanzapine cannot be explained by pharmacokinetics in the treatment of acute-phase schizophrenia.
Psychiatry Res
; 210(2): 396-401, 2013 Dec 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-23919898
11.
A comparison between augmentation with olanzapine and increased risperidone dose in acute schizophrenia patients showing early non-response to risperidone.
Psychiatry Res
; 198(2): 194-201, 2012 Jul 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-22421064
Resultados
1 -
11
de 11
1
Próxima >
>>